<SEC-DOCUMENT>0001104659-21-136387-index.html : 20211109 <SEC-HEADER>0001104659-21-136387.hdr.sgml : 20211109 <ACCEPTANCE-DATETIME>20211109172604 ACCESSION NUMBER: 0001104659-21-136387 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 EFFECTIVENESS DATE: 20211109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-260927 FILM NUMBER: 211393389 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2132065d1_s8.htm <DESCRIPTION>FORM S-8 <TEXT> Document 1 - file: tm2132065d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2132065d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2132065d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>tm2132065d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 3 - file: tm2132065d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2132065d1_ex5-1img01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2132065d1_ex5-1img01.jpg
</DOCUMENT> </SEC-DOCUMENT>